<DOC>
	<DOC>NCT01214135</DOC>
	<brief_summary>The primary objective of this non-interventional study is to investigate how Seroquel XR and Seroquel IR are used in the clinical practice of inpatients with schizophrenia. This will be done by a retrospective review of medical records to evaluate patients treated with Seroquel XR or Seroquel IR as primary antipsychotic treatment.</brief_summary>
	<brief_title>A Retrospective Non-interventional Study to Evaluate the Use of Seroquel Extended Release (XR) and Immediate Release (IR) in the Clinical Practice of Inpatients With Schizophrenia</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<criteria>Diagnosis of schizophrenia. At least one dose of Seroquel XR or Seroquel IR during the study period (1st of July 2009 30th of September 2010). Hospitalization due to psychotic symptoms at any time during the study period (1st of July 2009 30th of September 2010) and with admission and discharge dates available. Participation in a clinical trial during the study period. Treatment in forensic care according to LRV ("Lagen om Rättspsykiatrisk Vård").</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>Mental disorder</keyword>
	<keyword>antipsychotic treatment</keyword>
</DOC>